ERBB2 and neoplasm: Tumor cell proteins can elicit an immune response for various reasons; aberrant gene expression (e.g. cancer-testis antigens) [4-10], overexpression (neu/Her2) [11,12], aberrant processing (mucin) [13,14] and mutation events (p53) [11,15].